Schreuder et al. [31] did not find any influence of insulin resistance as assessed by HOMA index on intestinal FGF19 production in patients with non-alcohol fatty liver disease (NAFLD). This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatotic liver disease.